United States Securities and Exchange Commission · EDGAR Accession 0002088182-25-000004

Form C/A

Offering Statement Amendment — Regulation Crowdfunding
Campaign file 020-36411
Issuer CIK 2088182
Raising via MICROVENTURE MARKETPLACE INC.

EmerRx Biopharma, LLC

Limited Liability CompanyDEIncorporated 2025ALAMEDA, CAemerrx.com
Nature of amendmentAMENDMENT TO INCREASE THE MAXIMUM OFFERING AMOUNT FROM $250,000 TO $500,000.
A

The Offering

as disclosed in this filing
Other (CROWD NOTES)
$1.00
$25,000
$500,000
February 23, 2026
Expired 111 days ago
$0max $500,000

Target is 5% of the maximum. Over-subscriptions accepted.

B

Financial Condition

two fiscal years, as filed
Debt / assets 57%4 employees
Line itemMost recent FYPrior FYΔ
Revenue5000
Cost of goods sold00
Net income(209,440)0
Total assets80,3210
Cash & equivalents79,6210
Accounts receivable7000
Short-term debt46,0100
Long-term debt00
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.

C

Campaign Timeline

file 020-36411 · all filings under this campaign
Loading campaign history…